Sweden· SE-20180903000056
Drospirenone Exeltis 4 mg Filmdragerad tablett
A drospirenone product containing drospirenone + lactose., registered in Sweden by Exeltis Healthcare, S.L.. The same ATC class is registered in 13 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Drospirenone is registered in 13 of 19 countries.
Countries holding a registration under ATC G03AC10 (drospirenone), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 8 of them publish a price we can compare per daily dose
Drospirenone · ATC G03AC10
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Drospirenone + Lactose.
- Manufacturer
- Exeltis Healthcare, S.L.
- Country
- Sweden (SE)
- ATC code
- G03AC10
- ATC class
- Drospirenone
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20180903000056
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
172 interactions on record for drospirenone.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Drospirenone · interactions on record
172 records
- 27 severe
- 143 moderate
- 2 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- KetoconazoleH02CA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Drospirenone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Lyzbet
- Belgium · Slinda
- Bulgaria · Slinda
- Czechia · Zlynda
- Germany · Slinda
- Denmark · Slinda
- Estonia · Zlynda
- Spain · Slinda
- Finland · Slinda
- France · Slinda
- United Kingdom (Northern Ireland) · Slynd
- Croatia · Slinda
- Hungary · Slinda
- Ireland · Slyndy
- Iceland · Slinda
- Italy · Slinda
- Lithuania · Zlynda
- Luxembourg · Slinda
- Latvia · Zlynda
- Netherlands · Slinda
- Norway · Slinda
- Poland · Slinda
- Portugal · Slinda
- Romania · Slinda
- Slovenia · Slinda
- Slovakia · Zlynda
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c79a2aec-bf90-4aa7-83b6-5b61aa687f19 GET /v1/drugs/c79a2aec-bf90-4aa7-83b6-5b61aa687f19?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PAR",
"sPAR",
"SmPC",
"PL",
"sRMP"
],
"se_npl_id": "20180903000056",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20180903000056",
"product_doc_link": "https://docetp.mpa.se/LMF/Drospirenone%20Exeltis%20film-coated%20tablet%20ENG%20SmPC_09001bee807a2a16.pdf"
}See everything about drospirenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.